216 related articles for article (PubMed ID: 28888564)
21. Radiological case of the month. Tuberous sclerosis.
Jalou H; Hutcheon R; Sanz A
Arch Pediatr Adolesc Med; 2001 Jan; 155(1):89-90. PubMed ID: 11177070
[No Abstract] [Full Text] [Related]
22. Neonatal rhabdomyoma with cardiac dysfunction: favourable response to sirolimus.
Duan M; Sundararaghavan S; Koh AL; Soh SY
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35332001
[TBL] [Abstract][Full Text] [Related]
23. Rapid response of a cardiac rhabdomyoma causing severe right ventricular outflow obstruction to Sirolimus in an infant with negative genetics for Tuberous sclerosis.
Nir-David Y; Brosilow S; Khoury A
Cardiol Young; 2021 Feb; 31(2):312-314. PubMed ID: 33148352
[TBL] [Abstract][Full Text] [Related]
24. Radiological case of the month. Tuberous sclerosis with myocardial and central nervous system involvement at birth.
Allison JW; Stephenson CA; Angtuaco TL; Glasier CM; Wood BP
Am J Dis Child; 1991 Apr; 145(4):471-2. PubMed ID: 2012033
[No Abstract] [Full Text] [Related]
25. Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect.
Mohamed I; Ethier G; Goyer I; Major P; Dahdah N
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25427930
[TBL] [Abstract][Full Text] [Related]
26. Is mTOR inhibition a systemic treatment for tuberous sclerosis?
Moavero R; Coniglio A; Garaci F; Curatolo P
Ital J Pediatr; 2013 Sep; 39():57. PubMed ID: 24044547
[TBL] [Abstract][Full Text] [Related]
27. Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus.
Mlczoch E; Hanslik A; Luckner D; Kitzmüller E; Prayer D; Michel-Behnke I
Ultrasound Obstet Gynecol; 2015 May; 45(5):618-21. PubMed ID: 24913039
[TBL] [Abstract][Full Text] [Related]
28. [Tuberous sclerosis complex and cardiac rhabdomyoma].
Liu X
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):234-7. PubMed ID: 24824399
[No Abstract] [Full Text] [Related]
29. Sirolimus Can Increase the Disappearance Rate of Cardiac Rhabdomyomas Associated with Tuberous Sclerosis: A Prospective Cohort and Self-Controlled Case Series Study.
Chen XQ; Wang YY; Zhang MN; Lu Q; Pang LY; Liu LY; Li YF; Zou LP
J Pediatr; 2021 Jun; 233():150-155.e4. PubMed ID: 33631166
[TBL] [Abstract][Full Text] [Related]
30. Everolimus as a possible prenatal treatment of in utero diagnosed subependymal lesions in tuberous sclerosis complex: a case report.
Cavalheiro S; da Costa MDS; Richtmann R
Childs Nerv Syst; 2021 Dec; 37(12):3897-3899. PubMed ID: 34008055
[TBL] [Abstract][Full Text] [Related]
31. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study.
Ebrahimi-Fakhari D; Mann LL; Poryo M; Graf N; von Kries R; Heinrich B; Ebrahimi-Fakhari D; Flotats-Bastardas M; Gortner L; Zemlin M; Meyer S
Orphanet J Rare Dis; 2018 Jul; 13(1):117. PubMed ID: 30016967
[TBL] [Abstract][Full Text] [Related]
32. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma.
Davis KA; Dodeja AK; Clark A; Hor K; Baker P; Cripe LH; Cripe TP
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31088894
[TBL] [Abstract][Full Text] [Related]
33. Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities.
Kotulska K; Larysz-Brysz M; Grajkowska W; Jóźwiak J; Włodarski P; Sahin M; Lewin-Kowalik J; Domańska-Pakieła D; Jóźwiak S
Pediatr Dev Pathol; 2009; 12(2):89-95. PubMed ID: 17990907
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.
Saffari A; Brösse I; Wiemer-Kruel A; Wilken B; Kreuzaler P; Hahn A; Bernhard MK; van Tilburg CM; Hoffmann GF; Gorenflo M; Hethey S; Kaiser O; Kölker S; Wagner R; Witt O; Merkenschlager A; Möckel A; Roser T; Schlump JU; Serfling A; Spiegler J; Milde T; Ziegler A; Syrbe S
Orphanet J Rare Dis; 2019 May; 14(1):96. PubMed ID: 31053163
[TBL] [Abstract][Full Text] [Related]
35. Pre-excitation syndrome secondary to cardiac rhabdomyomas in tuberous sclerosis.
Mas C; Penny DJ; Menahem S
J Paediatr Child Health; 2000 Feb; 36(1):84-6. PubMed ID: 10723700
[TBL] [Abstract][Full Text] [Related]
36. [Bourneville tuberous sclerosis manifested by prenatal finding of intracardiac tumors].
Destuynder R; Menget A; Fromentin C; Burguet A; Noir A; Bernard Y; Feldmann M; Maucler Jolly R
Pediatrie; 1992; 47(4):279-84. PubMed ID: 1329012
[TBL] [Abstract][Full Text] [Related]
37. [Spontaneous regression of a heart rhabdomyoma in tuberous sclerosis. Apropos of a case].
Miró Guitart C; Perich MR; Miró Relat MR; Martín Santana J; Pineda V; Escofet C; Miró Bedós X
Rev Esp Cardiol; 1989 Dec; 42(10):697-700. PubMed ID: 2623304
[TBL] [Abstract][Full Text] [Related]
38. Rapid enlargement of cardiac rhabdomyoma during corticotropin therapy for infantile spasms.
Hishitani T; Hoshino K; Ogawa K; Uehara R; Kitazawa R; Hamano S; Nara T; Ogawa Y
Can J Cardiol; 1997 Jan; 13(1):72-4. PubMed ID: 9039068
[TBL] [Abstract][Full Text] [Related]
39. Rapid regression everolimus therapy in a neonate with cardiac rhabdomyoma.
Çetiner N; Kavas N; Küçükosmanoğlu O
Pediatr Int; 2022 Jan; 64(1):e15188. PubMed ID: 35605248
[No Abstract] [Full Text] [Related]
40. Tuberous sclerosis and cardiac rhabdomyoma.
Nir A; Tajik AJ; Freeman WK; Seward JB; Offord KP; Edwards WD; Mair DD; Gomez MR
Am J Cardiol; 1995 Aug; 76(5):419-21. PubMed ID: 7639176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
